Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
2,672,488
-
Share change
-
+310,213
-
Total reported value
-
$2,270,000
-
Price per share
-
$0.85
-
Number of holders
-
12
-
Value change
-
+$229,407
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) as of Q3 2019
As of 30 Sep 2019 ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,672,488 shares of stock of the company.
Largest 10 holders included SABBY MANAGEMENT, LLC, TYNDALL CAPITAL PARTNERS L P, 683 Capital Management, LLC, Point72 Asset Management, L.P., Kepos Capital LP, WELLS FARGO & COMPANY/MN, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and DIMENSIONAL FUND ADVISORS LP.
This table shows 12 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.